Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal. All content is subject to the portal’s Community Content Guidelines.
Karin Hellsvik
Vice President, Head of IR & Comms; Strategic Advisor
Foghorn Therapeutics
Executive with 20+ years of experience and passion for improving patient care; building long-term value for biotech investors View (0) Answers
Eric Hanson
CEO
MILMED Connect
CEO of MILMED Connect. Dual-use life sciences tech. MD from Uniformed Services Univ. MPH epidemiology with genetics from Johns Hopkins. View (0) Answers
Madelyn De Los Santos
Senior Advisor
Putnam Insights LLC
Communications and strategic positioning professional at Putnam Insights supporting biotech, medtech, AI, and women’s health innovators. View (0) Answers
Robert Barich
Managing Director
CNR Search
25+ years in executive search, life sciences investing, and company-building to match leaders with business needs. View (0) Answers
Tetsu Yung
Director of JAPAC Strategy
Glafabra Therapeutics
Building JAPAC strategy for Glafabra to advance durable, cell-based therapy for Fabry disease patients View (0) Answers
Eydith Comenencia Ortiz
Founder
CONECTA
Executive with 15 years of experience advancing biotech innovation with evidence-based patient engagement & insights generation View (0) Answers
